Stock Track | Addus HomeCare Plummets 8.81% in Intraday Trading After Barclays Maintains Sell Rating and Cuts Price Target
Stock Track
Feb 24
Addus HomeCare's stock price plummeted 8.81% during intraday trading on Tuesday, following negative analyst actions from Barclays.
The sharp decline came after Barclays maintained its Sell (Underweight) rating on the company and reduced its price target from $117 to $112. Analyst Andrew Mok CFA reaffirmed the negative outlook in reports released just before the market opened, signaling continued bearish sentiment toward the home care services provider.
Such analyst rating downgrades and price target reductions often trigger significant market reactions as they influence investor perceptions and trading decisions, particularly when coming from major financial institutions like Barclays.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.